Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS
出版年份 2019 全文链接
标题
Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-08-12
DOI
10.1038/s41598-019-48256-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dual requirement for STAT signaling in dendritic cell immunobiology
- (2018) Gloria Donninelli et al. IMMUNOBIOLOGY
- PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
- (2018) Haidong Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Checkpoint inhibitors and acute myelogenous leukemia: promises and challenges
- (2018) Mansour Alfayez et al. Expert Review of Hematology
- Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
- (2018) Michaël Cerezo et al. NATURE MEDICINE
- Mechanisms of Immune Tolerance in Leukemia and Lymphoma
- (2017) Emily K. Curran et al. TRENDS IN IMMUNOLOGY
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification
- (2016) Krishna V. Komanduri et al. Annual Review of Medicine
- The untold story of IFN-γ in cancer biology
- (2016) M. Alper Kursunel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Functional exhaustion of CD4+T cells induced by co-stimulatory signals from myeloid leukaemia cells
- (2016) Didem Ozkazanc et al. IMMUNOLOGY
- Acute Myeloid Leukemia: A Concise Review
- (2016) Jennifer Saultz et al. Journal of Clinical Medicine
- CRAM-A indicates IFN-γ-associated inflammatory response in breast cancer
- (2015) Parisa Sarmadi et al. MOLECULAR IMMUNOLOGY
- Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis
- (2015) Shuangnian Xu et al. PLoS One
- Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis
- (2014) Jordi Juncà et al. ANNALS OF HEMATOLOGY
- Recent developments in myelodysplastic syndromes
- (2014) R. Bejar et al. BLOOD
- STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia
- (2014) Øystein Bruserud et al. Expert Review of Hematology
- Negative Interactions and Feedback Regulations Are Required for Transient Cellular Response
- (2014) Mohammad Mobashir et al. Scientific Reports
- Adaptive resistance: A tumor strategy to evade immune attack
- (2013) Sheng Yao et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immune evasion in acute myeloid leukemia: current concepts and future directions
- (2013) Ryan M Teague et al. Journal for ImmunoTherapy of Cancer
- Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
- (2012) B. Will et al. BLOOD
- Myeloid leukemia cells with a B7-2+subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands
- (2012) Yusuf Dolen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy
- (2012) Tolga Sutlu et al. HUMAN GENE THERAPY
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor
- (2011) M. S. Redell et al. BLOOD
- Interferon- and tumor necrosis factor- induce an immunoinhibitory molecule, B7-H1, via nuclear factor- B activation in blasts in myelodysplastic syndromes
- (2010) A. Kondo et al. BLOOD
- In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
- (2010) Céline Berthon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PD-L1 expression on tolerogenic APCs is controlled by STAT-3
- (2010) Sabine J. Wölfle et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity
- (2010) Jelle J Lindenberg et al. Immunotherapy
- Sorafenib Inhibits STAT3 Activation to Enhance TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
- (2010) S. Huang et al. MOLECULAR CANCER THERAPEUTICS
- How I treat acute promyelocytic leukemia
- (2009) M. S. Tallman et al. BLOOD
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases
- (2009) Xiaoyu Hu et al. IMMUNITY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- The High-Mobility Group A1a/Signal Transducer and Activator of Transcription-3 Axis: An Achilles Heel for Hematopoietic Malignancies?
- (2008) J. Hillion et al. CANCER RESEARCH
- Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
- (2008) M. Marzec et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now